Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide

Saved in:
Bibliographic Details
Published in:Diabetes & metabolism 2019-01, Vol.45 (1), p.83-85
Main Authors: Lee, J.-Y., Kim, G., Lee, Y.-H., Lee, B.-W., Cha, B.-S., Nam, C.M., Kang, E.S.
Format: Article
Language:English
Subjects:
Aged
Carcinoma, Hepatocellular - epidemiology
Carcinoma, Hepatocellular - etiology
Female
Gliclazide - adverse effects
Humans
Hypoglycemic Agents - adverse effects
Incidence
Liver Neoplasms - epidemiology
Liver Neoplasms - etiology
Male
Middle Aged
Risk
Sulfonylurea Compounds - adverse effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1262-3636
1878-1780
DOI:10.1016/j.diabet.2017.06.007